Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EVO – Evotec SE

EVO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.03

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

-0.36

EPS This/Next Y

0.54

Price

3

Target Price

4

Analyst Recom

2.09

Performance Q

-16.67

Upside

-835.0%

Beta

1.95

Ticker: EVO




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13EVO2.77N/AN/A0
2026-04-14EVO3.12N/AN/A0
2026-04-15EVO3.22N/AN/A0
2026-04-16EVO3.22N/AN/A0
2026-04-17EVO3.26N/AN/A0
2026-04-20EVO3.16N/AN/A0
2026-04-21EVO3.24N/AN/A0
2026-04-22EVO3.3N/AN/A0
2026-04-23EVO3.22N/AN/A0
2026-04-24EVO3.15N/AN/A0
2026-04-27EVO3.13N/AN/A0
2026-04-28EVO3N/AN/A0
2026-04-29EVO2.93N/AN/A0
2026-04-30EVO3.1N/AN/A0
2026-05-01EVO3.1N/AN/A0
2026-05-04EVO3.13N/AN/A0
2026-05-05EVO3.14N/AN/A0
2026-05-06EVO3.23N/AN/A0
2026-05-07EVO3.06N/AN/A0
2026-05-08EVO3.08N/AN/A0
2026-05-11EVO3.05N/AN/A0
2026-05-12EVO2.98N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-13EVO2.78- 57.2-0.37
2026-04-14EVO3.12- 55.5-0.37
2026-04-15EVO3.21- 54.6-0.37
2026-04-16EVO3.21- 54.6-0.37
2026-04-17EVO3.25- 51.6-0.26
2026-04-20EVO3.15- 52.5-0.26
2026-04-21EVO3.24- 51.6-0.26
2026-04-22EVO3.30- 9.2-0.26
2026-04-23EVO3.23- 11.2-0.26
2026-04-24EVO3.15- 9.3-0.26
2026-04-27EVO3.13- 9.0-0.26
2026-04-28EVO3.00- 11.7-0.26
2026-04-29EVO2.93- 11.1-0.26
2026-04-30EVO3.10- 4.5-0.26
2026-05-01EVO3.10- 8.3-0.26
2026-05-04EVO3.12- 9.8-0.26
2026-05-05EVO3.15- 11.0-0.26
2026-05-06EVO3.23- 9.7-0.26
2026-05-07EVO3.06- -1.7-0.26
2026-05-08EVO3.08- 104.6-0.26
2026-05-11EVO3.06- 103.7-0.26
2026-05-12EVO3.00- 106.9-0.70
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-13EVO0.00-2.920.10
2026-04-14EVO0.00-2.920.10
2026-04-15EVO0.00-2.920.10
2026-04-17EVO0.00-2.920.10
2026-04-20EVO0.00-3.230.10
2026-04-21EVO0.00-3.230.10
2026-04-22EVO0.00-3.230.10
2026-04-23EVO0.00-3.230.10
2026-04-24EVO0.00-3.230.10
2026-04-27EVO0.00-54.860.12
2026-04-28EVO0.00-54.860.12
2026-04-29EVO0.00-54.860.12
2026-04-30EVO0.00-54.860.12
2026-05-01EVO0.00-54.860.12
2026-05-04EVO0.00-47.790.12
2026-05-05EVO0.00-47.790.12
2026-05-06EVO0.00-47.790.12
2026-05-07EVO0.00-47.790.12
2026-05-08EVO0.00-47.790.12
2026-05-11EVO0.00-46.060.12
2026-05-12EVO0.00-46.060.03
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

0.09

Avg. EPS Est. Next Quarter

-0.07

Insider Transactions

Institutional Transactions

-46.06

Beta

1.95

Average Sales Estimate Current Quarter

169

Average Sales Estimate Next Quarter

184

Fair Value

Quality Score

33

Growth Score

33

Sentiment Score

13

Actual DrawDown %

88.7

Max Drawdown 5-Year %

-91.3

Target Price

4

P/E

Forward P/E

PEG

P/S

1.23

P/B

1.32

P/Free Cash Flow

EPS

-0.63

Average EPS Est. Cur. Y​

-0.7

EPS Next Y. (Est.)

-0.16

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-26.08

Relative Volume

0.84

Return on Equity vs Sector %

-54.6

Return on Equity vs Industry %

-35.8

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.35

EBIT Estimation

106.9
EVO Healthcare
$3.00
📉
Swing / Pullback
Buy the dip on strong trends
39 /100
WEAK
Trend
8/20
Pullback
11/25
Volume
7/15
Valuation
12/20
TP/AR
1/10
Options
0/10
RSI
48.7
Range 1M
37.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
12 /100
WEAK
Momentum
4/25
Growth
8/30
Estimates
0/20
Inst/Vol
0/15
Options
0/10
EPS Yr
-15.7%
EPS NY
82.9%
52W%
26.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +33.3% upside
Quality
2/30
Valuation
10/30
Growth
6/25
Stability
4/10
LT Trend
5/5
Upside
+33.3%
Quality
33
Evotec SE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 4526
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
EVO

Latest News

Caricamento notizie per EVO
stock quote shares EVO – Evotec SE Stock Price stock today
news today EVO – Evotec SE stock forecast ,stock prediction 2023 2024 2025
marketwatch EVO – Evotec SE yahoo finance google finance
stock history EVO – Evotec SE invest stock market
stock prices EVO premarket after hours
ticker EVO fair value insiders trading

VJET – Voxeljet AG ADR

VJET — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.11

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

0.19

Price

1

Target Price

2.67

Analyst Recom

1

Performance Q

-45.29

Upside

N/A

Beta

1.07

Ticker: VJET




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13VJET0.6401N/AN/A0
2026-04-14VJET0.6401N/AN/A0
2026-04-15VJET0.6401N/AN/A0
2026-04-20VJET0.6401N/AN/A0
2026-04-23VJET0.6401N/AN/A0
2026-04-24VJET0.6401N/AN/A0
2026-04-27VJET0.6401N/AN/A0
2026-04-28VJET0.6401N/AN/A0
2026-04-29VJET0.6401N/AN/A0
2026-04-30VJET0.6401N/AN/A0
2026-05-01VJET0.6401N/AN/A0
2026-05-04VJET0.6401N/AN/A0
2026-05-05VJET0.6401N/AN/A0
2026-05-06VJET0.6401N/AN/A0
2026-05-07VJET0.6401N/AN/A0
2026-05-08VJET0.6401N/AN/A0
2026-05-11VJET0.6401N/AN/A0
2026-05-12VJET0.6401N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




No data found




No data found

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.49

Avg. EPS Est. Next Quarter

-0.3

Insider Transactions

Institutional Transactions

80.2

Beta

1.07

Average Sales Estimate Current Quarter

7

Average Sales Estimate Next Quarter

13

Fair Value

Quality Score

32

Growth Score

75

Sentiment Score

83

Actual DrawDown %

97.5

Max Drawdown 5-Year %

-98.7

Target Price

2.67

P/E

Forward P/E

PEG

P/S

0.18

P/B

0.38

P/Free Cash Flow

EPS

-1.2

Average EPS Est. Cur. Y​

-1.62

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-34.59

Relative Volume

Return on Equity vs Sector %

-119.2

Return on Equity vs Industry %

-106.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

VJET

Latest News

Caricamento notizie per VJET
stock quote shares VJET – Voxeljet AG ADR Stock Price stock today
news today VJET – Voxeljet AG ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch VJET – Voxeljet AG ADR yahoo finance google finance
stock history VJET – Voxeljet AG ADR invest stock market
stock prices VJET premarket after hours
ticker VJET fair value insiders trading

IMTX – Immatics N.V

IMTX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

4.59

Margin Of Safety %

Put/Call OI Ratio

0.22

EPS Next Q Diff

-0.12

EPS Last/This Y

0.13

EPS This/Next Y

-0.03

Price

11.36

Target Price

18.55

Analyst Recom

1

Performance Q

14.7

Upside

-307.7%

Beta

1.31

Ticker: IMTX




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13IMTX10.860.380.001210
2026-04-14IMTX10.950.370.001214
2026-04-15IMTX10.990.380.001207
2026-04-20IMTX11.230.030.00206
2026-04-23IMTX11.140.080.09243
2026-04-24IMTX11.360.085.00245
2026-04-27IMTX11.340.100.00251
2026-04-28IMTX11.60.10999.99265
2026-04-29IMTX11.210.10999.99265
2026-04-30IMTX10.980.100.67265
2026-05-01IMTX10.780.10999.99270
2026-05-04IMTX11.160.121.33275
2026-05-05IMTX10.940.140.50282
2026-05-06IMTX11.490.140.50282
2026-05-07IMTX11.140.140.00285
2026-05-08IMTX11.360.140.59285
2026-05-11IMTX11.540.22999.99366
2026-05-12IMTX11.350.22999.99366
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-13IMTX10.85-18.7- -1.74
2026-04-14IMTX10.94-18.7- -1.74
2026-04-15IMTX10.99-18.7- -1.74
2026-04-16IMTX10.86-18.7- -1.74
2026-04-17IMTX11.18-19.3- -1.75
2026-04-20IMTX11.25-19.3- -1.75
2026-04-21IMTX11.21-19.3- -1.75
2026-04-22IMTX11.26-19.3- -1.75
2026-04-23IMTX11.15-19.3- -1.75
2026-04-24IMTX11.36-19.3- -1.75
2026-04-27IMTX11.33-19.3- -1.75
2026-04-28IMTX11.61-19.3- -1.75
2026-04-30IMTX10.97-19.3- -1.75
2026-05-01IMTX10.79-19.3- -1.75
2026-05-04IMTX11.15-19.5- -1.75
2026-05-05IMTX10.94-19.5- -1.75
2026-05-06IMTX11.49-19.5- -1.75
2026-05-07IMTX11.14-19.5- -1.75
2026-05-08IMTX11.36-19.5- -1.75
2026-05-11IMTX11.54-19.5- -1.75
2026-05-12IMTX11.36-19.5- -1.75
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-13IMTX0.007.544.79
2026-04-14IMTX0.007.544.79
2026-04-15IMTX0.007.544.79
2026-04-16IMTX0.007.544.79
2026-04-17IMTX0.007.544.79
2026-04-20IMTX0.007.544.79
2026-04-21IMTX0.007.544.79
2026-04-22IMTX0.007.544.60
2026-04-23IMTX0.007.544.60
2026-04-24IMTX0.007.544.60
2026-04-27IMTX0.007.694.56
2026-04-28IMTX0.007.694.56
2026-04-29IMTX0.007.694.56
2026-04-30IMTX0.007.694.56
2026-05-01IMTX0.007.694.56
2026-05-04IMTX0.007.804.56
2026-05-05IMTX0.007.804.56
2026-05-06IMTX0.007.804.56
2026-05-07IMTX0.007.804.56
2026-05-08IMTX0.007.804.56
2026-05-11IMTX0.006.314.56
2026-05-12IMTX0.006.314.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.34

Avg. EPS Est. Current Quarter

-0.44

Avg. EPS Est. Next Quarter

-0.46

Insider Transactions

Institutional Transactions

6.31

Beta

1.31

Average Sales Estimate Current Quarter

11

Average Sales Estimate Next Quarter

10

Fair Value

Quality Score

29

Growth Score

32

Sentiment Score

78

Actual DrawDown %

30.3

Max Drawdown 5-Year %

-77.4

Target Price

18.55

P/E

Forward P/E

PEG

P/S

28.28

P/B

2.69

P/Free Cash Flow

EPS

-1.82

Average EPS Est. Cur. Y​

-1.75

EPS Next Y. (Est.)

-1.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-411.76

Relative Volume

1.03

Return on Equity vs Sector %

-67.4

Return on Equity vs Industry %

-51.9

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

IMTX Healthcare
$11.39
📉
Swing / Pullback
Buy the dip on strong trends
30 /100
WEAK
Trend
0/20
Pullback
10/25
Volume
4/15
Valuation
8/20
TP/AR
2/10
Options
6/10
RSI
56.8
Range 1M
61.5%
Sup Dist
0.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
6/25
Growth
7/30
Estimates
0/20
Inst/Vol
9/15
Options
7/10
EPS Yr
-0%
EPS NY
-0.1%
52W%
87.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +62.9% upside
Quality
2/30
Valuation
12/30
Growth
3/25
Stability
8/10
LT Trend
1/5
Upside
+62.9%
Quality
29
Immatics N.V.
Sector: Healthcare
Industry: Biotechnology
Employees: 589
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes Anzu-cel (IMA203), a one-time infusion PRAME cell therapy, which is in Phase 2 trial; IMA203CD8, a cell therapy product that is in Phase 1 clinical trial; IMA204 that targets tumor stroma, which is in Phase 1 clinical trial; and Anzu-cel in combination with Moderna's PRAME cell therapy enhancer (mRNA-4203), which is in Phase 1 clinical trial. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.
IMTX

Latest News

Caricamento notizie per IMTX
stock quote shares IMTX – Immatics N.V Stock Price stock today
news today IMTX – Immatics N.V stock forecast ,stock prediction 2023 2024 2025
marketwatch IMTX – Immatics N.V yahoo finance google finance
stock history IMTX – Immatics N.V invest stock market
stock prices IMTX premarket after hours
ticker IMTX fair value insiders trading

FMS – Fresenius Medical Care AG ADR

FMS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.26

Margin Of Safety %

7

Put/Call OI Ratio

2.62

EPS Next Q Diff

0.03

EPS Last/This Y

0.48

EPS This/Next Y

0.91

Price

22.23

Target Price

24.37

Analyst Recom

3.06

Performance Q

-7.47

Upside

88.0%

Beta

0.79

Ticker: FMS




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13FMS23.691.110.003241
2026-04-14FMS23.241.10999.993261
2026-04-15FMS22.841.100.673264
2026-04-20FMS23.182.680.031178
2026-04-23FMS22.751.850.001331
2026-04-24FMS22.761.850.001331
2026-04-27FMS22.621.850.001332
2026-04-28FMS22.511.84999.991334
2026-04-29FMS22.171.84999.991334
2026-04-30FMS22.561.860.001344
2026-05-01FMS22.51.86114.001345
2026-05-04FMS22.652.090.171460
2026-05-05FMS20.172.0719.591467
2026-05-06FMS21.012.664.501811
2026-05-07FMS21.662.670.001834
2026-05-08FMS22.012.690.921850
2026-05-11FMS21.752.61999.991854
2026-05-12FMS22.232.62999.991859
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-13FMS23.7118.9-82.32.90
2026-04-14FMS23.2418.9-93.22.90
2026-04-15FMS22.8418.9-93.82.90
2026-04-16FMS22.7918.9-78.72.90
2026-04-17FMS23.4218.9-41.62.90
2026-04-20FMS23.1818.9-81.12.90
2026-04-21FMS22.9518.6-75.82.90
2026-04-22FMS22.8618.6-69.32.90
2026-04-23FMS22.7518.6-66.42.90
2026-04-24FMS22.7618.6-55.52.90
2026-04-27FMS22.6118.6-61.82.88
2026-04-28FMS22.5118.6-59.72.88
2026-04-30FMS22.5618.6-31.42.88
2026-05-01FMS22.4918.6-54.12.88
2026-05-04FMS22.6618.6-39.52.88
2026-05-05FMS20.1718.6-174.72.88
2026-05-06FMS21.0118.60.52.88
2026-05-07FMS21.6513.914.12.50
2026-05-08FMS22.0213.9-75.42.50
2026-05-11FMS21.757.4-101.72.46
2026-05-12FMS22.236.3-67.72.45
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-13FMS0.00-0.200.31
2026-04-14FMS0.00-0.200.31
2026-04-15FMS0.00-0.200.31
2026-04-16FMS0.00-0.200.31
2026-04-17FMS0.00-0.200.31
2026-04-20FMS0.00-0.380.31
2026-04-21FMS0.00-0.380.31
2026-04-22FMS0.00-0.380.31
2026-04-23FMS0.00-0.380.31
2026-04-24FMS0.00-0.380.31
2026-04-27FMS0.00-0.450.28
2026-04-28FMS0.00-0.450.28
2026-04-29FMS0.00-0.450.28
2026-04-30FMS0.00-0.450.28
2026-05-01FMS0.00-0.450.28
2026-05-04FMS0.00-0.470.28
2026-05-05FMS0.00-0.470.28
2026-05-06FMS0.00-0.470.28
2026-05-07FMS0.00-0.470.28
2026-05-08FMS0.00-0.470.29
2026-05-11FMS0.00-0.560.29
2026-05-12FMS0.00-0.560.26
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.53

Avg. EPS Est. Current Quarter

0.48

Avg. EPS Est. Next Quarter

0.56

Insider Transactions

Institutional Transactions

-0.56

Beta

0.79

Average Sales Estimate Current Quarter

4734

Average Sales Estimate Next Quarter

4904

Fair Value

23.83

Quality Score

63

Growth Score

60

Sentiment Score

37

Actual DrawDown %

47.6

Max Drawdown 5-Year %

-68.8

Target Price

24.37

P/E

11.7

Forward P/E

8.81

PEG

2.11

P/S

0.54

P/B

0.79

P/Free Cash Flow

5.91

EPS

1.9

Average EPS Est. Cur. Y​

2.45

EPS Next Y. (Est.)

3.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.88

Relative Volume

1.32

Return on Equity vs Sector %

-19.7

Return on Equity vs Industry %

-111.1

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.45

EBIT Estimation

-67.7
FMS Healthcare
$22.23
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
13/25
Volume
3/15
Valuation
14/20
TP/AR
0/10
Options
2/10
RSI
49
Range 1M
60%
Sup Dist
2.6%
🚀
Momentum Growth
Ride accelerating trends
N/A
13 /100
WEAK
Momentum
1/25
Growth
3/30
Estimates
4/20
Inst/Vol
2/15
Options
3/10
EPS Yr
-7.3%
EPS NY
8%
52W%
21.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +120.3% upside
Quality
6/30
Valuation
20/30
Growth
3/25
Stability
3/10
LT Trend
1/5
Upside
+120.3%
Quality
63
MoS
7%
Fresenius Medical Care AG
Sector: Healthcare
Industry: Medical Care Facilities
Employees: 108165
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
FMS

Latest News

Caricamento notizie per FMS
stock quote shares FMS – Fresenius Medical Care AG ADR Stock Price stock today
news today FMS – Fresenius Medical Care AG ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch FMS – Fresenius Medical Care AG ADR yahoo finance google finance
stock history FMS – Fresenius Medical Care AG ADR invest stock market
stock prices FMS premarket after hours
ticker FMS fair value insiders trading

FMS – Fresenius Medical Care AG & Co. KGaA

FMS — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.26

Margin Of Safety %

7

Put/Call OI Ratio

2.62

EPS Next Q Diff

0.03

EPS Last/This Y

0.48

EPS This/Next Y

0.91

Price

22.23

Target Price

24.37

Analyst Recom

3.06

Performance Q

-7.47

Upside

88.0%

Beta

0.79

Ticker: FMS




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13FMS23.691.110.003241
2026-04-14FMS23.241.10999.993261
2026-04-15FMS22.841.100.673264
2026-04-20FMS23.182.680.031178
2026-04-23FMS22.751.850.001331
2026-04-24FMS22.761.850.001331
2026-04-27FMS22.621.850.001332
2026-04-28FMS22.511.84999.991334
2026-04-29FMS22.171.84999.991334
2026-04-30FMS22.561.860.001344
2026-05-01FMS22.51.86114.001345
2026-05-04FMS22.652.090.171460
2026-05-05FMS20.172.0719.591467
2026-05-06FMS21.012.664.501811
2026-05-07FMS21.662.670.001834
2026-05-08FMS22.012.690.921850
2026-05-11FMS21.752.61999.991854
2026-05-12FMS22.232.62999.991859
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-13FMS23.7118.9-82.32.90
2026-04-14FMS23.2418.9-93.22.90
2026-04-15FMS22.8418.9-93.82.90
2026-04-16FMS22.7918.9-78.72.90
2026-04-17FMS23.4218.9-41.62.90
2026-04-20FMS23.1818.9-81.12.90
2026-04-21FMS22.9518.6-75.82.90
2026-04-22FMS22.8618.6-69.32.90
2026-04-23FMS22.7518.6-66.42.90
2026-04-24FMS22.7618.6-55.52.90
2026-04-27FMS22.6118.6-61.82.88
2026-04-28FMS22.5118.6-59.72.88
2026-04-30FMS22.5618.6-31.42.88
2026-05-01FMS22.4918.6-54.12.88
2026-05-04FMS22.6618.6-39.52.88
2026-05-05FMS20.1718.6-174.72.88
2026-05-06FMS21.0118.60.52.88
2026-05-07FMS21.6513.914.12.50
2026-05-08FMS22.0213.9-75.42.50
2026-05-11FMS21.757.4-101.72.46
2026-05-12FMS22.236.3-67.72.45
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-13FMS0.00-0.200.31
2026-04-14FMS0.00-0.200.31
2026-04-15FMS0.00-0.200.31
2026-04-16FMS0.00-0.200.31
2026-04-17FMS0.00-0.200.31
2026-04-20FMS0.00-0.380.31
2026-04-21FMS0.00-0.380.31
2026-04-22FMS0.00-0.380.31
2026-04-23FMS0.00-0.380.31
2026-04-24FMS0.00-0.380.31
2026-04-27FMS0.00-0.450.28
2026-04-28FMS0.00-0.450.28
2026-04-29FMS0.00-0.450.28
2026-04-30FMS0.00-0.450.28
2026-05-01FMS0.00-0.450.28
2026-05-04FMS0.00-0.470.28
2026-05-05FMS0.00-0.470.28
2026-05-06FMS0.00-0.470.28
2026-05-07FMS0.00-0.470.28
2026-05-08FMS0.00-0.470.29
2026-05-11FMS0.00-0.560.29
2026-05-12FMS0.00-0.560.26
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.53

Avg. EPS Est. Current Quarter

0.48

Avg. EPS Est. Next Quarter

0.56

Insider Transactions

Institutional Transactions

-0.56

Beta

0.79

Average Sales Estimate Current Quarter

4734

Average Sales Estimate Next Quarter

4904

Fair Value

23.83

Quality Score

63

Growth Score

60

Sentiment Score

37

Actual DrawDown %

47.6

Max Drawdown 5-Year %

-68.8

Target Price

24.37

P/E

11.7

Forward P/E

8.81

PEG

2.11

P/S

0.54

P/B

0.79

P/Free Cash Flow

5.91

EPS

1.9

Average EPS Est. Cur. Y​

2.45

EPS Next Y. (Est.)

3.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

4.88

Relative Volume

1.32

Return on Equity vs Sector %

-19.7

Return on Equity vs Industry %

-111.1

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.45

EBIT Estimation

-67.7
FMS Healthcare
$22.23
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
13/25
Volume
3/15
Valuation
14/20
TP/AR
0/10
Options
2/10
RSI
49
Range 1M
60%
Sup Dist
2.6%
🚀
Momentum Growth
Ride accelerating trends
N/A
13 /100
WEAK
Momentum
1/25
Growth
3/30
Estimates
4/20
Inst/Vol
2/15
Options
3/10
EPS Yr
-7.3%
EPS NY
8%
52W%
21.3%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +120.3% upside
Quality
6/30
Valuation
20/30
Growth
3/25
Stability
3/10
LT Trend
1/5
Upside
+120.3%
Quality
63
MoS
7%
Fresenius Medical Care AG
Sector: Healthcare
Industry: Medical Care Facilities
Employees: 108165
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
FMS

Latest News

Caricamento notizie per FMS
stock quote shares FMS – Fresenius Medical Care AG & Co. KGaA Stock Price stock today
news today FMS – Fresenius Medical Care AG & Co. KGaA stock forecast ,stock prediction 2023 2024 2025
marketwatch FMS – Fresenius Medical Care AG & Co. KGaA yahoo finance google finance
stock history FMS – Fresenius Medical Care AG & Co. KGaA invest stock market
stock prices FMS premarket after hours
ticker FMS fair value insiders trading

SSU – SIGNA Sports United N.V.

SSU — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

0.16

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.02

Target Price

3.92

Analyst Recom

3.5

Performance Q

-96.71

Upside

N/A

Beta

0.55

Ticker: SSU




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-13SSU0.0937N/AN/A0
2026-04-14SSU0.0937N/AN/A0
2026-04-15SSU0.0937N/AN/A0
2026-04-16SSU0.0937N/AN/A0
2026-04-17SSU0.0937N/AN/A0
2026-04-20SSU0.0937N/AN/A0
2026-04-21SSU0.0937N/AN/A0
2026-04-22SSU0.0937N/AN/A0
2026-04-23SSU0.0937N/AN/A0
2026-04-24SSU0.0937N/AN/A0
2026-04-27SSU0.0937N/AN/A0
2026-04-28SSU0.0937N/AN/A0
2026-04-29SSU0.0937N/AN/A0
2026-04-30SSU0.0937N/AN/A0
2026-05-01SSU0.0937N/AN/A0
2026-05-04SSU0.0937N/AN/A0
2026-05-05SSU0.0937N/AN/A0
2026-05-06SSU0.0937N/AN/A0
2026-05-07SSU0.0937N/AN/A0
2026-05-08SSU0.0937N/AN/A0
2026-05-11SSU0.0937N/AN/A0
2026-05-12SSU0.0937N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




No data found




No data found

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

0.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

29

Growth Score

32

Sentiment Score

24

Actual DrawDown %

99.8

Max Drawdown 5-Year %

Target Price

3.92

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-1.08

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-137

Return on Equity vs Industry %

-170

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

SSU

Latest News

Caricamento notizie per SSU
stock quote shares SSU – SIGNA Sports United N.V. Stock Price stock today
news today SSU – SIGNA Sports United N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch SSU – SIGNA Sports United N.V. yahoo finance google finance
stock history SSU – SIGNA Sports United N.V. invest stock market
stock prices SSU premarket after hours
ticker SSU fair value insiders trading
No more stocks to show